VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 33 | -58.2% | 0.00% | – |
| Q4 2017 | $2,000 | -94.4% | 79 | -94.6% | 0.00% | -100.0% |
| Q3 2016 | $36,000 | +176.9% | 1,472 | +126.5% | 0.01% | +200.0% |
| Q2 2016 | $13,000 | -90.4% | 650 | -87.5% | 0.00% | -91.7% |
| Q1 2016 | $136,000 | -57.0% | 5,188 | +67.1% | 0.02% | -59.3% |
| Q4 2015 | $316,000 | – | 3,104 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |